Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Silibinin is a novel and ancient molecule that highlights the significance of integrated therapies for cancer.

2.

Key mechanism behind prostate cancer drug resistance reveals potential new treatment strategy

3.

Immunotherapy-TACE Regimen Boosts PFS in Unresectable Liver Cancer

4.

Omega Fatty Acid Changes Tied to Lower Proliferation Rate in Early Prostate Cancer

5.

FDA Advisors Split on Regimens for Breast, Prostate Cancers


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot